Gene Biotherapeutics, Inc.

What is Gene Biotherapeutics, Inc. (CRXM) stock price today?

As of Oct 14, 2024, 8:00 PM UTC, Gene Biotherapeutics, Inc. (CRXM) stock is trading at $0.0001. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date CRXM stock quotes for informed trading decisions.

What is Gene Biotherapeutics, Inc.'s market capitalization?

Gene Biotherapeutics, Inc. (CRXM) has a market capitalization of approximately $6.5K. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Gene Biotherapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the CRXM stock price changes.

What is the 52-week range for Gene Biotherapeutics, Inc. stock?

Gene Biotherapeutics, Inc. (CRXM) stock has traded in a 52-week range of $0.00 — $0.0001. The 52-week range shows the highest and lowest prices at which CRXM traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Gene Biotherapeutics, Inc. stock price to this range provides context for recent price action.

How much trading volume does Gene Biotherapeutics, Inc. stock have?

Gene Biotherapeutics, Inc. (CRXM) stock recently traded approximately 5K shares. Trading volume indicates market liquidity and investor interest in CRXM. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Gene Biotherapeutics, Inc. stock.

Does Gene Biotherapeutics, Inc. pay dividends to shareholders?

Yes, Gene Biotherapeutics, Inc. (CRXM) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Gene Biotherapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Gene Biotherapeutics, Inc.'s intraday price range?

Today, Gene Biotherapeutics, Inc. (CRXM) stock has traded in a range of $0.00 — $0.0001. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring CRXM's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Gene Biotherapeutics, Inc. stock data?

AlphaPilot sources real-time CRXM stock quotes, fundamental financial data, and historical price charts for Gene Biotherapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Gene Biotherapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of CRXM stock performance.